During the year 2023, Prolabin & Tefarm made significant progress in the biomedical field. One of the most noteworthy advancements was the development of advanced functionalized dressings for treating non-healing diabetic ulcerative lesions. This treatment utilizes cross-linked chitosan carrier microspheres and has demonstrated promising results. A paper was presented on this topic at the 17th AIUC National Congress in Turin (11 – 14 October 2023), and we’ve included a case report from the proceeding book below for your review.